Evaluation Statement

• Performance-enhancing drug use presents significant risks and serious ethical concerns. Although some argue these concerns are overstated, the risks and ethical issues outweigh any performance benefits.

Health and Safety Risks

• Anabolic steroids cause liver damage, cardiovascular disease and hormonal disruptions that can persist beyond athletic careers.
• EPO increases blood viscosity, creating a high risk of stroke and heart attack, particularly during intense competition.
• Stimulants can produce cardiac arrhythmias and overheating, which can result in sudden death during performance.
• Many consequences emerge years after use ceases. For example, steroid use in adolescents can cause premature growth plate closure, permanently stunting height.
• Female athletes can experience masculinisation effects such as voice deepening and increased body hair, some of which are irreversible.
• Mental health impacts include depression, aggression and dependency, affecting quality of life beyond sport.

Ethical and Fair Play Issues

• Drug use provides unfair advantages over clean athletes, devaluing achievement earned through training and talent.
• When drug use is widespread, clean athletes may feel pressured to use drugs to remain competitive, putting their own health at risk.
• Elite athletes are role models, and their drug use sends a dangerous message to young participants who may copy these practices.
• This normalises cheating and damages public trust in sport.

Counter-Arguments

• Some argue that drug use should be permitted because testing does not catch every user, so allowing medically supervised use would make competition fairer and reduce the risks of unsupervised use.
• Others point out that the ethical line is unclear. For example, altitude tents are legal, yet they raise red blood cell levels in a similar way to EPO, which is banned.
• However, permitting drug use would increase the pressure on clean athletes to use drugs, and high doses would remain harmful even under supervision.
• The comparison with altitude training is also limited, because natural adaptations are restricted by the body, while drugs can push red blood cell levels to dangerous extremes.

Final Evaluation

• Weighing these factors shows that performance-enhancing drugs present unacceptable risks and serious ethical violations.
• While arguments for supervised use and the blurred line with legal methods raise valid questions, they do not outweigh the health dangers and the pressure placed on clean athletes.
• Overall, drug use remains fundamentally incompatible with fair and ethical athletic participation.

Evaluation Statement

• The use of performance-enhancing drugs by elite athletes can produce real performance gains.
• However, it is highly problematic, as severe health risks and ethical violations far outweigh these short-term benefits.

Performance Benefits

• Performance-enhancing drugs produce genuine performance gains, which explains why some elite athletes are willing to risk using them.
• Anabolic steroids increase muscle mass and strength and speed recovery between sessions, allowing athletes to train harder and more often.
• EPO increases red blood cell production, improving oxygen delivery to working muscles and endurance performance.
• At the elite level, these gains can decide results, with selection, prize money and sponsorship at stake. However, they are temporary and depend on avoiding detection, which limits their value.

Health Implications

• Anabolic steroids create substantial health risks, including liver damage, cardiovascular disease and hormonal disruption that can last long after use.
• For example, prolonged steroid use can cause heart attacks, liver tumours, testicular atrophy and psychological effects such as aggression and depression.
• EPO thickens the blood, which can lead to strokes, pulmonary embolism and heart failure.
• Growth hormone abuse can cause joint damage, diabetes and abnormal bone growth.
• These effects can cause lasting damage to organs and psychological wellbeing, outweighing short-term performance gains.

Ethical Considerations and Drug Testing

• Performance-enhancing drugs provide unfair advantages that undermine sporting achievement based on talent, dedication and training.
• For example, when Lance Armstrong used EPO, he cheated competitors who competed cleanly and deceived millions of fans who believed in his achievements.
• Drug testing catches many offenders through advanced testing methods. However, new substances constantly emerge, and sophisticated doping programs can evade detection through micro-dosing and designer drugs.
• The ethical damage extends beyond individual cheating to pressure on clean athletes, influence on young athletes and erosion of public trust in sport.

Final Evaluation

• Weighing these factors shows that performance-enhancing drugs are highly detrimental to elite sport and athlete welfare.
• Although they can improve strength, recovery and endurance, these gains are temporary and come at the cost of serious long-term health risks and the integrity of competition.
• While detection systems are partly effective, drug use fundamentally contradicts the core values of sport and athlete safety, and its costs clearly outweigh its benefits.